[Federal Register Volume 82, Number 117 (Tuesday, June 20, 2017)]
[Notices]
[Pages 28082-28083]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-12851]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Agency Information Collection Activities: Submission for OMB 
Review; Comment Request

    Periodically, the Substance Abuse and Mental Health Services 
Administration (SAMHSA) will publish a summary of information 
collection requests under OMB review, in compliance with the Paperwork 
Reduction Act (44 U.S.C. Chapter 35). To request a copy of these 
documents, call the SAMHSA Reports Clearance Officer at (240) 276-1243.

Project: Strategic Prevention Framework for Prescription Drugs (SPF-
Rx)--New

    The Substance Abuse and Mental Health Services Administration 
(SAMHSA)'s Center for Substance Abuse Prevention (CSAP) aims to conduct 
a cross-site evaluation of the Strategic Prevention Framework for 
Prescription Drug (SPF-Rx) program. The SPF-Rx program is designed to 
address nonmedical use of prescription drugs (as well as) opioid 
overdoses by raising awareness about the dangers of sharing medications 
and by working with pharmaceutical and medical communities. The SPF-Rx 
program aims to promote collaboration between states/tribes and 
pharmaceutical and medical communities to understand the risks of 
overprescribing to youth age 12-17 and adults 18 years of age and 
older. The program also aims to enhance capacity for, and access to, 
Prescription Drug Monitoring Program (PDMP) data for prevention 
purposes.
    The SPF-Rx program aims to address SAMHSA's priorities on 
prevention and reduction of prescription drug and illicit opioid misuse 
and abuse. Its indicators of success are reductions in opioid overdoses 
and the incorporation of PDMP data into needs assessments and strategic 
plans. Data collected through the tools described in this statement 
will be used for the national cross-site evaluation of SAMHSA's SPF-Rx 
program. This package covers continued data collection through 2020, as 
the evaluation is expected to continue through at least that time; 
however, the Program Evaluation for Prevention Contract (PEP-C) is 
scheduled to conduct a national cross-site evaluation of SPF-Rx through 
September 2018. The PEP-C team will systematically collect and maintain 
an Annual Implementation Instrument (AII) and outcomes data submitted 
by SPF-Rx grantees through the online PEP-C Management Reporting Tool 
(MRT).
    SAMHSA is requesting approval for data collection for the SPF-Rx 
cross-site evaluation with the following four instruments:
     Grantee Interview to obtain the perspective of the 
implementing Project Directors (PDs) or their staff on important 
topics, including infrastructure and capacity, collaboration, 
leveraging funding and resources, criteria and use of evidence-informed 
interventions, monitoring and evaluation, collaboration, challenges, 
and health disparities. Information from these interviews will help 
inform SPF-Rx cross-site evaluation reports and will help identify 
lessons learned and success stories from grantees' SPF-Rx programs.
     Grantee- and Community-Level Outcomes Modules to collect 
data on key SPF-Rx program outcomes, including opioid misuse and abuse, 
opioid overdoses, and opioid prescribing patterns. Grantees will 
provide outcomes data at the grantee level for their state, tribal 
area, or jurisdiction, as well as at the community level for each of 
their subrecipient communities.
     Substitute Data Source Request to allow grantees to 
request permission from SAMHSA to use ``substitute measures'' for their 
outcomes data--that is, measures that differ from a list of preapproved 
outcomes measures.
     Annual Implementation Instrument to collect data completed 
by grantees and subrecipient community PDs. Data collected from the 
survey will be used to monitor subrecipient and state, tribal entity, 
or jurisdiction performance and to evaluate the effectiveness of the 
SPF-Rx program across states, tribal entities, and jurisdictions.
     Grantee Interview to collect semistructured telephone 
interview data to gather more in-depth information on organizational 
infrastructure, use of PDMP data, collaboration, leveraging of funds 
and resources, and evaluation activities
     Evaluation Plan to allow grantees to outline their local 
evaluation plan. Sections include goals and objectives, performance 
measures, data analysis plan, and reporting plan.

                                        Annualized Data Collection Burden
----------------------------------------------------------------------------------------------------------------
                                     Number of    Responses  per   Total  number     Hours per     Total burden
           Instrument               respondents     respondent     of responses      response          hours
----------------------------------------------------------------------------------------------------------------
Grantee-Level Outcomes Module...              25               1              25               3              75
Community-Level Outcomes Module.              25               1              25               3              75
Substitute Data Request Form....              12               1              12               1              12
Annual Implementation Instrument             100               1             100             2.3             230
Grantee-Level Interview.........              17               1              17             1.5            25.5
Evaluation Plan.................              25               1              25               8             200
                                 -------------------------------------------------------------------------------
    Overall Total...............             100  ..............             204  ..............             618
----------------------------------------------------------------------------------------------------------------
Note. Annualized Data Collection Burden captures the average number of respondents and responses, burden hours,
  and respondent cost over the 3 years (FY2018-FY2020).

    Written comments and recommendations concerning the proposed 
information collection should be sent by July 20, 2017 to the SAMHSA 
Desk Officer at the Office of Information and Regulatory Affairs, 
Office of Management and Budget (OMB). To ensure timely receipt of 
comments, and to avoid potential delays in OMB's receipt and processing 
of mail sent through the U.S. Postal Service, commenters are encouraged 
to submit their comments to OMB via email to: 
[email protected]. Although commenters are encouraged to

[[Page 28083]]

send their comments via email, commenters may also fax their comments 
to: 202-395-7285. Commenters may also mail them to: Office of 
Management and Budget, Office of Information and Regulatory Affairs, 
New Executive Office Building, Room 10102, Washington, DC 20503.

Summer King,
Statistician.
[FR Doc. 2017-12851 Filed 6-19-17; 8:45 am]
BILLING CODE 4162-20-P